1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow Shengke Pharmaceuticals Pty Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| First-in Human (FIH) Trial of ETH-155008 in Subjects With B-NHL, CLL/SLL and AML ETH-155008 - NHL, Leukemia | Phase 1 | Terminated | Shengke Pharmaceuticals Pty Ltd | 9 | 2021-06-29 | 2023-10-11 |
Leukemia (1)
Drug Evaluation (1)
Australia (1)
James Zhang (1)